| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 143.74B | 146.17B | 145.64B | 142.02B | 128.84B | 155.46B |
| Gross Profit | 23.37B | 23.60B | 25.09B | 19.00B | 19.30B | 19.37B |
| EBITDA | 196.00M | 2.20B | 14.89B | 12.67B | 16.25B | 10.11B |
| Net Income | -8.83B | -7.81B | 3.02B | 1.35B | 4.26B | 375.00M |
Balance Sheet | ||||||
| Total Assets | 111.21B | 124.63B | 140.56B | 131.80B | 137.13B | 132.89B |
| Cash, Cash Equivalents and Short-Term Investments | 15.07B | 19.97B | 19.66B | 18.25B | 18.37B | 17.95B |
| Total Debt | 19.27B | 21.02B | 24.83B | 26.57B | 26.79B | 24.28B |
| Total Liabilities | 48.62B | 59.72B | 64.13B | 61.11B | 65.05B | 62.75B |
| Stockholders Equity | 61.45B | 63.66B | 75.12B | 69.33B | 70.69B | 68.81B |
Cash Flow | ||||||
| Free Cash Flow | 1.86B | 2.68B | 8.00B | 1.32B | -3.97B | 2.23B |
| Operating Cash Flow | 6.84B | 9.35B | 14.76B | 9.49B | 3.43B | 9.69B |
| Investing Cash Flow | -2.00B | -3.75B | -6.63B | -5.31B | -1.14B | -5.26B |
| Financing Cash Flow | -4.36B | -6.41B | -7.22B | -5.31B | -2.82B | 1.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥190.15B | 9.32 | 4.41% | 3.80% | -1.50% | -32.46% | |
68 Neutral | ¥2.23T | 8.67 | 8.29% | 2.89% | 3.55% | 95.65% | |
65 Neutral | ¥87.94B | 17.82 | ― | 0.67% | 10.18% | -14.36% | |
64 Neutral | ¥24.18B | 17.30 | ― | 4.09% | 3.31% | -70.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥526.91B | 67.20 | 1.02% | 3.37% | -1.94% | -84.08% | |
52 Neutral | ¥34.06B | -143.95 | ― | 4.66% | -6.34% | -419.93% |